 | Up a level |
Number of items: 2.
Alzubi, J., Dettmer, V., Kuehle, J., Seidl, M., Taromi, S., Zeiser, R., Abken, H., Cathomen, T. and Wolf, P. (2018). A novel chimeric antigen receptor CAR-T cell approach eliminates prostate cancer in a mouse tumour model. Hum. Gene Ther., 29 (12). S. A21 - 1. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7422
Kuehle, J., Hofmann, P., Chmielewski, M. and Abken, H. (2017). T cell-directed enzyme-prodrug therapy (TDEPT): CAR T cells engineered for tumour-restricted activation of cytotoxic prodrugs. Hum. Gene Ther., 28 (12). S. A38 - 1. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7422